168 related articles for article (PubMed ID: 37968926)
1. Palmoplantar pustulosis with psoriatic arthritis ineffective to interleukin-17 inhibitors: two patients successfully treated with upadacitinib.
Zhang ZY; Mi WY; Wang YY; Li W
J Dermatolog Treat; 2023 Dec; 34(1):2280508. PubMed ID: 37968926
[TBL] [Abstract][Full Text] [Related]
2. [Palmoplantar pustulosis].
Berbis P
Rev Prat; 1991 Oct; 41(22):2165-8. PubMed ID: 1784916
[TBL] [Abstract][Full Text] [Related]
3. The Efficacy of Biologic Therapy for the Management of Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review.
Sanchez IM; Sorenson E; Levin E; Liao W
Dermatol Ther (Heidelb); 2017 Dec; 7(4):425-446. PubMed ID: 29143230
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of severe arthralgia associated with palmoplantar pustulosis with low-dose oral cyclosporine A.
Yamamoto T; Kimura K; Katayama I; Nishioka K
J Dermatol; 1995 Jul; 22(7):512-4. PubMed ID: 7560444
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics analysis of guselkumab in healthy subjects and patients with psoriatic arthritis, plaque psoriasis and palmoplantar pustulosis.
Tran L; Yao Z; Xu Z; Vermeulen A
Br J Clin Pharmacol; 2022 Oct; 88(10):4481-4493. PubMed ID: 35470450
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and prevalence of plaque psoriasis in patients with palmoplantar pustulosis.
Andersen YMF; Augustin M; Petersen J; Hagenström K; Mallbris L; Burge R; Egeberg A
Br J Dermatol; 2019 Nov; 181(5):976-982. PubMed ID: 30815849
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and Burdens of Disease in Patients from Beijing with Generalized Pustular Psoriasis and Palmoplantar Pustulosis: Multicenter Retrospective Cohort Study Using a Regional Database.
Wang HM; Xu JM; Jin HZ
Am J Clin Dermatol; 2023 Nov; 24(6):991-1002. PubMed ID: 37386353
[TBL] [Abstract][Full Text] [Related]
8. A Case Series of TNF Inhibitor-Induced Psoriasis Successfully Treated With Upadacitinib.
Woodbury MJ; Grant C; Perez-Chada L; LaChance AH; Merola JF
J Drugs Dermatol; 2024 Feb; 23(2):e60-e63. PubMed ID: 38306123
[TBL] [Abstract][Full Text] [Related]
9. Use of upadacitinib in the treatment of psoriatic arthritis.
Ross Y; Magrey M
Immunotherapy; 2021 Dec; 13(18):1549-1554. PubMed ID: 34645316
[TBL] [Abstract][Full Text] [Related]
10. Interleukin (IL)-17 Versus IL-23 Inhibitors: Which Is Better to Treat Patients With Moderate-to-Severe Psoriasis and Mild Psoriatic Arthritis in Dermatology Clinics?
Agüero R; Woodbury MJ; Lee K; Johnsson HJ; Merola JF; Armstrong AW
J Rheumatol; 2023 Nov; 50(Suppl 2):11-13. PubMed ID: 37419622
[TBL] [Abstract][Full Text] [Related]
11. Pustular Psoriasis: A Narrative Review of Recent Developments in Pathophysiology and Therapeutic Options.
Menter A; Van Voorhees AS; Hsu S
Dermatol Ther (Heidelb); 2021 Dec; 11(6):1917-1929. PubMed ID: 34626330
[TBL] [Abstract][Full Text] [Related]
12. Principal Component Analysis to Differentiate Patients with Palmoplantar Pustulosis from Those with Palmoplantar Pustular Psoriasis.
Kim TH; Kim JS; Kwon JE; Park B; Lee ES
Ann Dermatol; 2022 Feb; 34(1):7-13. PubMed ID: 35221589
[TBL] [Abstract][Full Text] [Related]
13. Risks of Comorbidities in Patients With Palmoplantar Pustulosis vs Patients With Psoriasis Vulgaris or Pompholyx in Korea.
Kim DH; Lee JY; Cho SI; Jo SJ
JAMA Dermatol; 2022 Jun; 158(6):650-660. PubMed ID: 35476054
[TBL] [Abstract][Full Text] [Related]
14. Adalimumab Biosimilar-Induced Severe Paradoxical Palmoplantar Pustulosis in a Patient with Psoriasis and Psoriatic Arthritis Successfully Treated with Ixekizumab.
Gkalpakiotis S; Fridman M; Tivadar S
Dermatol Ther (Heidelb); 2022 Feb; 12(2):605-609. PubMed ID: 35067854
[TBL] [Abstract][Full Text] [Related]
15. Palmoplantar pustulosis - a cross-sectional analysis in Germany.
Wilsmann-Theis D; Jacobi A; Frambach Y; Philipp S; Weyergraf A; Schill T; Steinz K; Gerdes S; Mössner R
Dermatol Online J; 2017 Apr; 23(4):. PubMed ID: 28541870
[TBL] [Abstract][Full Text] [Related]
16. Clinical and epidemiological comparison of patients affected by palmoplantar plaque psoriasis and palmoplantar pustulosis: a case series study.
Brunasso AM; Puntoni M; Aberer W; Delfino C; Fancelli L; Massone C
Br J Dermatol; 2013 Jun; 168(6):1243-51. PubMed ID: 23301847
[TBL] [Abstract][Full Text] [Related]
17. Psoriatic arthritis for dermatologists.
Gottlieb A; Merola JF
J Dermatolog Treat; 2020 Nov; 31(7):662-679. PubMed ID: 31014154
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in palmoplantar pustulosis.
Brunasso AMG; Massone C
Fac Rev; 2021; 10():62. PubMed ID: 34409425
[TBL] [Abstract][Full Text] [Related]
19. Does previous use of tumour necrosis inhibitors change the therapeutic effect of interleukin (IL)-17 or IL-12/23 inhibitors on psoriasis and psoriatic arthritis? Results of a systematic review.
Xie Y; Liu Y
Clin Exp Dermatol; 2022 Sep; 47(9):1627-1635. PubMed ID: 35466472
[TBL] [Abstract][Full Text] [Related]
20. Recalcitrant annular pustular psoriasis associated with psoriatic arthritis successfully treated with secukinumab.
Herrero-Moyano M; Capusan TM; Martínez-Mera C; Llamas-Velasco M; Daudén E
JAAD Case Rep; 2018 Sep; 4(8):842-844. PubMed ID: 30246137
[No Abstract] [Full Text] [Related]
[Next] [New Search]
